Related by context. All words. (Click for frequent words.) 75 alkylating agent 74 recurrent glioblastoma multiforme 73 docetaxel Taxotere ® 73 relapsed MM 73 colorectal liver metastases 72 CYT# potent vascular disrupting 72 sorafenib Nexavar 72 ZOLINZA 72 Methylnaltrexone 72 thalidomide Thalomid 71 receptor tyrosine kinase inhibitor 71 Pemetrexed 71 erlotinib Tarceva ® 71 invasive candidiasis 71 invasive aspergillosis 71 malignant pleural mesothelioma 71 denileukin diftitox 70 MGd 70 immunomodulatory therapy 70 GnRH agonists 70 relapsing remitting MS RRMS 70 acute GvHD 70 differentiated thyroid 70 dasatinib Sprycel ® 70 Hepatocellular Carcinoma HCC 70 postsurgical pain 70 gastrointestinal stromal tumors GIST 70 caspofungin 70 Dasatinib 70 cilengitide 69 Irinotecan 69 Aflibercept 69 metastatic malignant melanoma 69 MAGE A3 ASCI 69 Degarelix 69 urothelial cancer 69 bendamustine 69 basal cell carcinoma BCC 69 situ CIS 69 heavily pretreated 69 metastatic malignant 69 Bezielle 69 metastatic renal cell carcinoma 69 mycophenolate mofetil 69 tigecycline 69 indolent NHL 69 refractory NSCLC 69 recurrent ovarian cancer 69 Tamibarotene 69 Mitomycin C 69 lenalidomide Revlimid R 69 epithelial tumors 69 Certolizumab pegol 69 phase IIb clinical 69 INCB# [003] 69 relapsing multiple sclerosis 69 Mitoxantrone 69 prostate cancer HRPC 69 diabetic neuropathic pain 69 recurrent GBM 69 liposomal amphotericin B 69 intravesical 69 trastuzumab Herceptin ® 69 relapsed ovarian cancer 69 mRCC 69 Traficet EN 69 histone deacetylase inhibitor 69 ACTEMRA TM 69 Gleevec resistant 69 JAK inhibitor 69 visilizumab 69 YONDELIS 68 VFEND 68 octreotide 68 riociguat 68 leukemia CLL 68 intravesical instillation 68 intravesical therapy 68 allogeneic HSCT 68 Dapagliflozin 68 metastatic RCC 68 dexamethasone Decadron 68 Zolinza 68 refractory CLL 68 mitomycin C 68 oropharyngeal candidiasis 68 docetaxel chemotherapy 68 trabectedin 68 CANCIDAS 68 adriamycin 68 proteasome inhibitor 68 ritonavir boosted 68 OHR/AVR# 68 Deforolimus 68 candidemia 68 imatinib therapy 68 infliximab Remicade 68 diabetic gastroparesis 68 bevacizumab Avastin ® 68 micafungin 68 paroxysmal AF 68 factor Xa inhibitor 68 stage IIIB 68 primary immunodeficiency PI 68 resectable 68 targeted radiotherapeutic 68 VA# [002] 68 biliary tract cancer 68 trans retinoic acid ATRA 68 basiliximab 68 histone deacetylase HDAC inhibitor 68 cell lymphoma CTCL 68 pertuzumab 68 rFVIIa 68 liposomal formulation 68 grade cervical intraepithelial 68 dosage regimens 68 metastatic neuroendocrine tumors 68 Toxicities 68 deferiprone 68 leukemia AML 68 rituximab Rituxan 68 Myelodysplastic Syndrome MDS 68 pegfilgrastim 68 Anthracycline 68 investigational monoclonal antibody 68 clomipramine 68 gastric adenocarcinoma 68 fosbretabulin 68 Golimumab 67 BCG refractory 67 noninfectious uveitis 67 HER2 positive metastatic breast 67 Cloretazine 67 nucleoside analog 67 imatinib Gleevec ® 67 mapatumumab 67 VAPRISOL 67 pancreatic carcinoma 67 Sudhir Agrawal D.Phil 67 Gleevec imatinib 67 fallopian tube carcinoma 67 endometrial hyperplasia 67 recurrent malignant glioma 67 esophageal candidiasis 67 castrate resistant prostate cancer 67 oral prodrug 67 biologic therapy 67 alefacept 67 forodesine 67 Doxil ® 67 APTIVUS r 67 MabCampath 67 nab paclitaxel 67 resistant ovarian cancer 67 SCCHN 67 amphotericin B 67 prostate cancer CRPC 67 DAPT 67 imatinib Gleevec 67 synthetic retinoid 67 severe hypersensitivity reactions 67 treat benign prostatic 67 peripherally acting 67 voriconazole 67 Fludara ® 67 CCR5 antagonist 67 liver resection 67 overactive bladder syndrome 67 AEG# 67 ALA PDT 67 trans retinoic acid 67 vinca alkaloid 67 paclitaxel Taxol 67 diarrhea predominant irritable 67 stable angina 67 renal tumors 67 Fludarabine 67 alvespimycin 67 peritumoral brain edema 67 fallopian tube cancers 67 Ophena TM 67 bortezomib Velcade 67 LHRH receptor positive 67 antiangiogenic therapy 67 cetuximab Erbitux R 67 Enzyme Replacement Therapy 67 anterior uveitis 67 busulfan 67 metastatic colorectal 67 BAY #-# 67 ketolide antibiotic 67 luteinizing hormone releasing 67 metastatic bladder 67 idarubicin 67 aflibercept VEGF Trap 67 myelodysplastic myeloproliferative diseases 67 recurrent glioma 67 ganciclovir 67 Chronic Myelogenous Leukemia CML 67 alkylating agents 67 antiandrogens 67 Seliciclib 67 Tolvaptan 67 TORISEL 67 prucalopride 67 HQK 67 concurrent chemoradiation 67 Vorinostat 67 CHOP chemotherapy 67 calcineurin inhibitors 67 Genasense ® 67 intravenous bisphosphonates 67 docetaxel Taxotere R 67 hepatocellular carcinoma HCC 67 docetaxel Taxotere 67 Tocilizumab 67 corticosteroid therapy 67 Decitabine 67 Tyrima 67 PEGylated interferon beta 1a 67 antiarrhythmic drug 67 AA amyloidosis 67 galiximab 67 bleomycin 67 protein kinase inhibitor 67 TNF alpha inhibitor 67 idiopathic thrombocytopenic purpura ITP 67 immunosuppressant drug 67 assessing T DM1 67 Hydroxyurea 67 taxane resistant 67 OncoVEX GM CSF 67 adalimumab Humira 66 ZYVOX 66 AA Amyloidosis 66 chemoradiotherapy 66 inhibitor RG# 66 Navelbine ® 66 anthracycline chemotherapy 66 Erlotinib 66 salmeterol fluticasone 66 LEUKINE 66 sorafenib tablets 66 Cyclosporine 66 urothelial carcinoma 66 malignant lymphomas 66 vinca alkaloids 66 systemic fungal infections 66 HCV SPRINT 66 ovarian carcinoma 66 CIMZIA ™ 66 Combination therapy 66 Amrubicin 66 TKI therapy 66 monoclonal antibody conjugated 66 sodium stibogluconate 66 Teriflunomide 66 Bortezomib 66 lexidronam injection 66 demonstrated antitumor activity 66 antimetabolite 66 cutaneous T 66 Pafuramidine 66 gastrointestinal stromal tumor GIST 66 noscapine 66 hyperphenylalaninemia HPA due 66 IV NSCLC 66 Doxorubicin 66 nucleoside analogues 66 Capecitabine 66 Microplasmin 66 xanthine oxidase inhibitor 66 Eculizumab 66 recurrent genital herpes 66 posterior uveitis 66 Zavesca R 66 Surgical resection 66 mTOR inhibitors 66 eosinophilic asthma 66 superficial basal cell carcinoma 66 OMNARIS HFA 66 alpha interferon 66 VEGF inhibitors 66 myelofibrosis polycythemia vera 66 pancreatic adenocarcinoma 66 constipation OIC 66 erythropoietic 66 mycophenolate mofetil MMF 66 hypervascular tumors 66 malignant ascites 66 post herpetic neuralgia 66 chemotherapeutic regimens 66 cholangiocarcinoma 66 cediranib 66 bevacizumab Avastin 66 uric acid lowering 66 elacytarabine 66 posaconazole 66 non metastatic osteosarcoma 66 teriflunomide 66 Glucocorticoids 66 BRAF inhibitor 66 GISTs 66 hypercalcemia 66 PKC# 66 leukotriene receptor antagonists 66 lapatinib Tykerb 66 Platinol ® 66 anthracycline taxane 66 leiomyomas 66 Chemophase 66 Proxinium TM 66 chemotherapeutic agent 66 hyperplasia BPH 66 lomitapide 66 vidofludimus 66 OvaRex ® MAb 66 symptomatic BPH 66 GW# [003] 66 direct thrombin inhibitors 66 Talabostat 66 Iluvien TM 66 gamma secretase inhibitor 66 acute promyelocytic leukemia APL 66 taxane chemotherapy 66 Azedra 66 icatibant 66 antibody MAb 66 IMA# 66 GP IIb IIIa inhibitors 66 acetonide FA 66 Sapacitabine 66 metaglidasen 66 β blockers 66 5 Fluorouracil 66 Voreloxin 66 Crizotinib 66 selective modulator 66 DMARDs 66 Ozarelix 66 cutaneous squamous cell carcinoma 66 delayed CINV 66 protease inhibitor PI 66 papillary renal cell carcinoma 66 Vidaza azacitidine 66 advanced metastatic renal 66 benign prostatic hypertrophy BPH 66 postoperative ileus 66 DDP# 66 malignant neoplasms 66 plasma kallikrein inhibitor 66 ribavirin therapy 66 vorinostat 66 herpetic keratitis 66 Rilonacept 66 refractory AML 66 ADP receptor antagonist 66 MYCAMINE 66 Ranibizumab 66 recurrent glioblastoma 66 INVANZ 66 alpha interferons 66 T#I [002] 66 anti androgen 66 microwave hyperthermia 66 Octreotide 66 interferon alfa 2b 66 ribavirin RBV 66 cytotoxic therapy 66 somatostatin analog 66 standard chemotherapy regimen 66 glioblastoma multiforme GBM 66 adjunctively 66 HCV RESPOND 2 66 pulmonary hypertension PH 66 cytostatic 66 sulindac 66 BCR ABL mutations 66 angiogenesis inhibitor 66 Temsirolimus 66 hydroxychloroquine 66 Rheumatoid Arthritis RA 66 trastuzumab Herceptin R 66 KETEK 66 PEGylated 66 relapsed leukemia 66 Cancidas 66 CIMZIA TM certolizumab pegol 66 seminoma 66 IFN beta 66 pan HDAC inhibitor 66 relapsed refractory 66 pegylated interferon alfa 2a 66 etanercept Enbrel 66 Cytarabine 66 Aclidinium 66 chronic HCV 65 transarterial 65 SNT MC# 65 delafloxacin 65 vinorelbine 65 CIPN 65 drug zotarolimus 65 Maribavir 65 haematologic 65 injected subcutaneously 65 liver metastases 65 pouchitis 65 Afatinib 65 relapsed multiple myeloma 65 nonmetastatic 65 vismodegib 65 follicular lymphoma FL 65 HRPC 65 Vaprisol 65 HIV HCV coinfected 65 Gliadel Wafer 65 Liprotamase 65 Xanafide 65 prostate cancer PCa 65 symptomatic paroxysmal AF 65 NMIBC 65 familial amyloidotic polyneuropathy FAP 65 DOXIL 65 rilonacept 65 Pertuzumab 65 metastatic HRPC 65 Diabetic Macular Edema 65 Ranolazine 65 Cytoxan 65 immunomodulator 65 paroxetine Paxil 65 Chronic Lymphocytic Leukemia CLL 65 BoNTA 65 pegylated liposomal doxorubicin 65 relapsed refractory multiple myeloma 65 Tanespimycin 65 Trastuzumab 65 overactive bladder OAB 65 irinotecan chemotherapy 65 cidofovir 65 budesonide foam 65 FUSILEV enhances 65 primary hyperparathyroidism 65 thrombolytic agent 65 intradermal injection 65 TEMODAL 65 refractory ovarian cancer 65 essential thrombocythemia ET 65 LHRH agonists 65 subependymal giant cell 65 opioid induced constipation OIC 65 tumor xenograft models 65 Vicinium TM 65 immunocompetent patients 65 antitumor effect 65 neuroendocrine cancers 65 symptomatic benign prostatic 65 acute coronary syndromes ACS 65 Aliskiren 65 colorectal adenoma 65 TNF Tumor Necrosis Factor 65 metastatic CRC 65 recurrent prostate cancer 65 pomalidomide 65 Neovascular AMD 65 evaluating tivozanib 65 cisplatin gemcitabine 65 interferon ribavirin 65 polycythemia vera PV 65 radiation sensitizer 65 lupus nephritis 65 meropenem 65 platelet inhibitor 65 Adjuvant chemotherapy 65 SERMs 65 CR# vcMMAE 65 somatostatin analogues 65 ELACYT 65 fluvastatin 65 Neulasta ® 65 carcinoid tumors 65 FOLFOX4 65 anti arrhythmic drug 65 relapsed CLL 65 antiepileptics 65 TLK# 65 BEXXAR Therapeutic Regimen 65 oral rivaroxaban 65 lung metastases 65 Alinia 65 Nilotinib 65 granisetron 65 quinolone 65 Omacetaxine 65 elotuzumab 65 verteporfin 65 antimuscarinic 65 Adjunctive 65 corticosteroid dexamethasone 65 dasatinib Sprycel 65 Squalamine 65 flutamide 65 PEGylated Fab fragment 65 T2DM 65 unresectable tumors 65 multi kinase inhibitor 65 CBLC# 65 HCD# [002] 65 Gefitinib 65 Advanced Renal Cell 65 chemotherapy cisplatin 65 axitinib 65 platinum refractory 65 mitomycin 65 Carfilzomib 65 humanised monoclonal antibody 65 Retreatment 65 Candida infection 65 TG# [003] 65 ZACTIMA 65 BCG refractory carcinoma 65 Pathway Inhibitor 65 transurethral resection 65 PEGINTRON TM 65 nonmelanoma skin cancers 65 sunitinib malate 65 DEFLUX 65 orally bioavailable 65 intravenously administered 65 either acutely decompensated 65 EOquin TM phase 65 CCX# 65 radezolid 65 calcineurin inhibitor 65 SCIg 65 Intravesical 65 prostate carcinoma 65 HuMax EGFr 65 NeuroStar TMS Therapy 65 DMARDS 65 INVEGA ® 65 macrolide antibiotic 65 prednisone prednisolone 65 microtubule inhibitor 65 ziconotide 65 renal toxicity 65 heparin induced thrombocytopenia 65 gefitinib Iressa 65 anti angiogenic agents 65 lenalidomide dexamethasone 65 Velcade bortezomib 65 ESBA# 65 alpha blocker 65 toenail onychomycosis 65 oral vancomycin 65 PRTX 65 Intravenous immunoglobulin 65 cisplatin resistant 65 depsipeptide 65 efalizumab 65 proteasome inhibitors 65 Radezolid 65 TMS Therapy 65 orally administered inhibitor 65 mTOR inhibitor 65 pentoxifylline 65 liposomal doxorubicin 65 medically refractory 65 Onconase 65 skeletal metastases 65 ancrod 65 FOLFOX chemotherapy 65 CYT# QbG# 65 intranasal corticosteroid 65 cutaneous T cell 65 Dacogen decitabine 65 IV metastatic melanoma 65 Gemcitabine 65 hereditary deficiency 65 RhuDex ® 65 palifermin 65 octreotide acetate 65 DFMO 65 phase IIb trial 65 INTEGRILIN R 65 idraparinux 65 acne vulgaris 65 administered subcutaneously 65 cinacalcet 65 Tarceva TM 65 castration resistant prostate cancer 65 vandetanib 65 invasive fungal infections 65 radiolabeled TM# 65 pancreatic neuroendocrine tumors 65 chemoradiation therapy 65 post herpetic neuralgia PHN 65 TMP SMX 65 phase IIa clinical 65 pheochromocytoma 65 systemic corticosteroids 65 EGFR tyrosine kinase inhibitor 65 Blinatumomab 65 hepatic metastases 65 PEG SN# 65 neovascular diseases 65 refractory chronic myeloid 65 Soft Tissue Sarcoma 65 MMP inhibitors 65 Peginterferon alfa 2b 65 CEQ# 65 gastrointestinal stromal tumor 65 Bacillus Calmette Guerin BCG 65 cytoreductive surgery 65 Vidofludimus 65 olmesartan 65 EXJADE 64 rt PA 64 sulfasalazine 64 systemic RNAi therapeutic 64 lumiliximab 64 TNF antagonist 64 Cethromycin 64 Hycamtin 64 Noxafil 64 IBS C 64 metastatic GIST 64 PREZISTA r 64 Hodgkin lymphoma HL 64 proctitis 64 sorafenib Nexavar ® 64 mycosis fungoides 64 hyperalgesia 64 cetuximab Erbitux ® 64 medullary thyroid cancer 64 AKT inhibitor 64 gastrointestinal stromal tumors 64 HSP# inhibitor 64 psoriatic arthritis PsA 64 oral ridaforolimus 64 daunorubicin 64 Oral Mucositis 64 immunomodulatory properties 64 octreotide LAR 64 FOLFOX6 64 taxane therapy 64 prostate cancer CaP 64 Paraplatin ® 64 vWD 64 recurrent metastatic 64 cystic fibrosis bronchiectasis 64 Fondaparinux 64 Benign Prostatic Hyperplasia BPH 64 factor TNF 64 VEGF receptor inhibitor 64 basal cell nevus syndrome 64 atypical Hemolytic Uremic Syndrome 64 Onalta 64 Pegasys ® 64 cervical lesions 64 miconazole 64 Exemestane 64 hypereosinophilic syndrome 64 pegylated interferon alfa 64 EOquin 64 cyclosporin 64 Darusentan 64 octreotide implant 64 breast carcinoma 64 Sutent sunitinib 64 sunitinib Sutent ® 64 Ceftaroline 64 KRAS mutations occur 64 clinically localized prostate 64 #I TM# 64 de novo kidney transplant 64 refractory gout 64 Epratuzumab 64 disease modifying antirheumatic 64 antiandrogen 64 pediatric Crohn disease 64 MAL PDT 64 Azathioprine 64 somatostatin analogue 64 hepatoma 64 deep venous thromboses 64 peritoneal cancer 64 brand ciclesonide HFA 64 Fludara 64 miconazole Lauriad ® 64 daptomycin 64 nosocomial pneumonia 64 FASLODEX 64 canakinumab 64 Fluorouracil 64 pediatric malignancies 64 Anti VEGF 64 pseudobulbar affect PBA 64 colorectal cancer liver metastases 64 chemotherapeutic drug 64 Alemtuzumab 64 multiple myeloma MM 64 gemcitabine Gemzar 64 anakinra 64 antibiotic regimens 64 decitabine 64 analgesic efficacy 64 enzastaurin 64 alkylating 64 Panzem R NCD 64 metastatic gastric 64 chronic lymphocytic leukemia CLL 64 NP2 Enkephalin 64 small molecule tyrosine 64 mecamylamine 64 neuroendocrine tumors 64 HBeAg negative 64 tyrosine kinase inhibitor 64 talabostat 64 anticancer compound 64 chronic HBV 64 anti leukemic 64 benign prostatic hypertrophy 64 Bevacizumab 64 EOquin TM 64 sertraline Zoloft 64 masitinib 64 Metastatic Prostate Cancer 64 hepatocellular carcinomas 64 Chronic Prostatitis 64 reslizumab 64 bezafibrate 64 oropharyngeal candidiasis OPC 64 TACE 64 fistulizing Crohn disease 64 pancreatic NET 64 ethambutol 64 antiemetics 64 choroidal neovascularization 64 NMDA antagonists 64 kidney urologic 64 Idiopathic Pulmonary Fibrosis 64 Topotecan 64 acute humoral rejection 64 thromboembolic events 64 T#I mutation 64 null responder 64 Gemzar ® 64 oral anticoagulant 64 BARACLUDE ® 64 Atypical Hemolytic Uremic Syndrome 64 pyridostigmine 64 chemotherapeutic 64 Lubiprostone 64 pegylated interferon alpha 64 TNF alpha antagonist 64 MEK inhibitor 64 squamous cell carcinoma SCC 64 Carboplatin 64 myeloproliferative disorders 64 metastatic hormone refractory 64 Alpharadin 64 Metastatic Colorectal Cancer 64 EGFR tyrosine kinase inhibitors 64 ISTODAX 64 blinded randomized placebo controlled 64 immunocompetent 64 olanzapine Zyprexa 64 CTAP# Capsules 64 carcinoid syndrome 64 rufinamide 64 Naive Patients 64 Diabetic Macular Edema DME 64 grade glioma 64 pharmacodynamics PD 64 bexarotene 64 investigational humanized monoclonal antibody 64 BMS# 64 osteosarcomas 64 doxorubicin HCl liposome injection 64 Pamidronate 64 paricalcitol 64 AVASTIN 64 opioid induced constipation 64 cIAI 64 Pralatrexate 64 antihypertensive therapy 64 unresectable stage 64 CD3 monoclonal antibody 64 gemcitabine Gemzar ® 64 randomized multicenter trial 64 TACI Ig 64 acyclovir Lauriad R 64 HCV infection 64 SGS# 64 Estrogen Receptor 64 antifungal therapy 64 Daclizumab 64 CCR5 inhibitor 64 cardiac toxicity 64 Fidaxomicin 64 imipenem 64 panobinostat 64 Myocet 64 thymoma 64 chronic angina 64 antiarrhythmic drugs 64 NovoTTF 64 chimeric monoclonal antibody 64 recurrent herpes labialis 64 Neoadjuvant 64 vapreotide acetate 64 HER2 overexpression 64 Glioblastoma Multiforme 64 tolvaptan 64 transplantation HCT 64 gemcitabine cisplatin 64 milrinone 64 ureteral stents 64 imatinib resistant 64 HeFH 64 ceftazidime 64 HBeAg positive patients 64 OMP #M# 64 TREANDA 64 Bicalutamide 64 Platinol ® cisplatin 64 AGHD 64 mu opioid receptor antagonist 64 lymphadenopathy 64 macrolide antibiotics 64 LHRH analogues 64 IGF 1R inhibitor 64 unresectable 64 relapsing remitting multiple sclerosis 64 G#DT 64 Complicated Skin 64 AGILECT R 64 sunitinib 64 acadesine 64 ALN TTR 64 IV bisphosphonates 64 TTF Therapy 64 ß blockers 64 stage IIIb IV 64 olaparib 64 bladder carcinoma 64 mertansine 64 Azacitidine 64 Natalizumab 64 cervical intraepithelial neoplasia 64 Aviptadil 64 IAP inhibitor 64 Valproic acid 64 candidiasis 64 intravesical infusion therapy 64 nicardipine 64 Benign Prostatic Hyperplasia 64 hA# 64 APTIVUS ritonavir 64 dapsone 64 mutated KRAS gene 64 beclomethasone dipropionate 64 invasive fungal infection 64 pharmacokinetic interactions 64 haematological malignancies 64 huC# DM4 64 sitaxsentan 64 Protelos 64 LYSTEDA 64 colorectal carcinoma 64 artery embolization 64 nonsmall cell lung cancer 64 VP# [004] 64 pimozide 64 bone metastasis 64 humanized monoclonal 64 metastatic renal 64 heavily pretreated patients 64 SinuNase TM 64 prescribed proton pump 64 PICSO ® 64 intranasal formulation 64 chronic ITP patients 64 direct thrombin inhibitor 64 hypertrophic scars 64 LHRH antagonists 64 Solid Tumors 64 prostate adenocarcinoma 64 CAPHOSOL 64 Elotuzumab 64 nilotinib Tasigna ® 64 Bendamustine 64 JAK2 inhibitor 64 myelofibrosis MF 64 severe gastroparesis 64 Navelbine 64 Nexavar sorafenib 64 Acute Coronary Syndromes ACS 64 epithelial ovarian cancer 64 LHRH agonist 64 Losartan 64 secondary hyperparathyroidism 64 induce remission 64 Lixivaptan 64 NOXAFIL 64 targeted antifolate 64 FVIII inhibitors 64 catheter occlusion 64 idiopathic pulmonary fibrosis IPF 64 Enzastaurin 63 delivers fluocinolone acetonide FA 63 dosing cohort 63 Adalimumab 63 antithrombotics 63 Omacetaxine mepesuccinate 63 QTc prolongation 63 hepatorenal syndrome 63 renal cell carcinomas 63 Vidaza ® 63 Aplidin 63 phase IIb study 63 Metastatic Melanoma 63 EGFR inhibitors 63 Hormone Refractory Prostate Cancer 63 Pharmacokinetics PK 63 TNF inhibitors 63 inhaled bronchodilators 63 Romidepsin 63 Personalized Immunotherapy 63 intraperitoneal chemotherapy 63 rhITF 63 eosinophilic pneumonia 63 keloid scarring 63 CML CP 63 virus HCV protease inhibitor 63 nephrotoxicity 63 zotarolimus 63 pulmonary metastases 63 lanreotide 63 GSK# [001] 63 rituximab refractory 63 aripiprazole Abilify 63 antineoplastic 63 hematologic toxicity 63 ocular inflammation 63 palliative radiotherapy 63 grade gliomas 63 nonrandomized 63 radiochemotherapy 63 Ziprasidone 63 Sym# 63 LY# [003] 63 ALK inhibitor 63 dacarbazine DTIC 63 miglustat 63 HCV infections 63 galantamine 63 fibromyalgia syndrome 63 HNSCC 63 anti angiogenic drugs 63 PEGylated anti 63 trials RCTs 63 Lacosamide 63 azacitidine 63 Glioblastoma Multiforme GBM 63 MULTAQ 63 Alequel 63 opioid induced bowel dysfunction 63 recurrent NSCLC 63 infusional 63 HCV protease inhibitors 63 pegylated alpha interferon 63 refractory angina 63 prochlorperazine 63 azole 63 nucleotide analogue 63 mCRC patients 63 NSAID induced 63 EVIZON 63 Malignant Melanoma 63 prostate TURP 63 KRN# 63 Cisplatin 63 leukotriene receptor antagonist 63 urothelial bladder cancer 63 IMGN# 63 Hematologic 63 chronic GVHD 63 H pylori 63 pain palliation 63 Vascugel 63 acute HAE attacks 63 inhalation powder 63 velafermin 63 thrombin inhibitor 63 C1 INH